Stephen Smolinski - Jan 3, 2022 Form 3 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Signature
/s/ Christopher R. Sullivan, Attorney-in-Fact
Stock symbol
AVTX
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 03:16 PM
Next filing
Jan 6, 2022

No securities are beneficially owned.